Aytu Biopharma, INC Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
SCHEDULE 13D/A: Nantahala Capital Boosts Stake in Aytu BioPharma to 14.4% Through Prefunded Warrant Purchase
Nantahala Capital Management, LLC and its principals have increased their beneficial ownership in Aytu BioPharma, Inc. to 14.4% by acquiring prefunded warrants for 4 million shares in a recent underwritten offering.